This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics, after the company unveiled results for a potential golden bullet for...
Vous n'êtes pas connecté
- SMH.COM.AU - Business - 20/Jun 08:19
ASX Runners of the Week: Amplia, archTIS and Vanadium Resources
This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics, after the company unveiled results for a potential golden bullet for pancreatic cancer.
Articles similaires
ASX Runners of the Week: Amplia, archTIS and Vanadium Resources
thewest.com.au - 20/Jun 08:17
This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics. The biotech beauty might just be onto a fabled golden bullet for...
ASX Runners of the Week: Amplia, archTIS and Vanadium Resources
thewest.com.au - 20/Jun 08:17
This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics. The biotech beauty might just be onto a fabled golden bullet for...
ASX Runners of the Week: Ovanti, Olympio, Codeifai and Sunrise
smh.com.au - 27/Jun 07:10
This week’s Bulls N’ Bears ASX Runners of the Week is… Ovanti Ltd, after the company scored a buy now, pay later maestro to guide its US...
ASX Runners of the Week: Ovanti, Olympio, Codeifai and Sunrise
thewest.com.au - 27/Jun 07:10
This week’s Bulls N’ Bears ASX Runners of the Week is… Ovanti Ltd, after the company scored a buy now, pay later maestro and former Zip Co exec...
ASX Runners of the Week: Ovanti, Olympio, Codeifai and Sunrise
thewest.com.au - 27/Jun 07:10
This week’s Bulls N’ Bears ASX Runners of the Week is… Ovanti Ltd, after the company scored a buy now, pay later maestro and former Zip Co exec...
Top 10 at 11: ASX dips in early trade; Amplia achieves second pancreatic cancer complete response
stockhead.com.au - 19/Jun 00:56
The ASX dipped a tad in morning trade, with the tech and materials sectors lagging. Amplia Therapeutics has reported a ...
Tango Therapeutics begins patient dosing in phase 1/2 trial of TNG462 plus Revolution Medicines' daraxonrasib or zoldonrasib to treat RAS─mutant MTAP─deleted pancreatic or lung cancer
pharmabiz.com - 22:49
Tango Therapeutics, Inc., a clinical─stage biotechnology company committed to discovering the next generation of precision cancer medicines,...
Edgewise Therapeutics announces positive results on sevasemten programme for Becker and Duchenne muscular dystrophies
pharmabiz.com - 27/Jun 13:15
Edgewise Therapeutics, Inc., a leading muscle disease biopharmaceutical company, unveiled positive results in its sevasemten programme for Becker and...
Edgewise Therapeutics announces positive results on sevasemten programme for Becker and Duchenne muscular dystrophies
pharmabiz.com - 27/Jun 13:15
Edgewise Therapeutics, Inc., a leading muscle disease biopharmaceutical company, unveiled positive results in its sevasemten programme for Becker and...
Les derniers communiqués
-
Aucun élément